TY  - GEN 
AU  - Rossello, X.
AU  - Raposeiras Roubín, Sergio
AU  - Latini, R.
AU  - Dominguez-Rodriguez, A.
AU  - Barrabés, J.A.
AU  - Sánchez, P.L.
AU  - Anguita, M.
AU  - Fernández-Vázquez, F.
AU  - Pascual-Figal, D.
AU  - De la Torre Hernandez, J.M.
AU  - Ferraro, S.
AU  - Vetrano, A.
AU  - Pérez-Rivera, J.A.
AU  - Prada Delgado, Oscar
AU  - Escalera, N.
AU  - Staszewsky, L.
AU  - Pizarro, G.
AU  - Agüero, J.
AU  - Pocock, S.
AU  - Ottani, F.
AU  - Fuster, V.
AU  - Ibáñez, B.
PY  - 2022
SN  - 2055-6845
UR  - http://hdl.handle.net/20.500.11940/20523
AB  - AIMS: There is a lack of evidence regarding the benefits of ?-blocker treatment after invasively managed acute myocardial infarction (MI) without reduced left ventricular ejection fraction (LVEF). METHODS AND RESULTS: The tREatment with Beta-blockers...
LA  - eng
TI  - Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
DO  - 10.1093/ehjcvp/pvab060
KW  - AS Vigo
KW  - CHUVI
KW  - IISGS
KW  - AS Coruña
KW  - CHUAC
KW  - INIBIC
VL  - 8
ER  -